MedPath

pain management by siravedh chikitsa In Vatarakta

Not Applicable
Conditions
Health Condition 1: E799- Disorder of purine and pyrimidinemetabolism, unspecifiedHealth Condition 2: E799- Disorder of purine and pyrimidinemetabolism, unspecified
Registration Number
CTRI/2024/07/070686
Lead Sponsor
DR MAYURI DINESH THAKRE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients diagnose with Vatarakta. Patients with Uric Acid Level more than 7.0 mg/dl in male and more than 6.0 mg/dl in female

Exclusion Criteria

Patients known bleeding disorders. Patients with Anemia. patients with uncontrolled diabetes and Hypertension.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br/ ><br>1. Pain <br/ ><br> <br/ ><br>B.OBJECTIVE CRITERIA <br/ ><br>1. SwellingTimepoint: 8th Day
Secondary Outcome Measures
NameTimeMethod
Effect of Siravedh Chikitsa on Pain & Swelling in VataraktaTimepoint: After 1 week
© Copyright 2025. All Rights Reserved by MedPath